Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2026 · 10-Q
Revenue$1.86M$1.86M+34.3% vs Q2 2025 Net Income-$2.38M-$2.38MN/M vs Q2 2025 EPS Diluted-$0.28-$0.28N/M vs Q2 2025 Gross Profit$990,264+28.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,328,711N/M Free Cash Flowderived-$1,367,227N/M Margins · derivedGross margin53.2%−2.4 pt vs Q2 2025
Operating margin-128.7%+64.5 pt vs Q2 2025
Net margin-127.9%+35.8 pt vs Q2 2025
ended Mar 31, 2026 · filed May 12, 2026 · 42 d after period end